Phase I clinical study of humanized BCMA-single-domain antibodies targeting CAR-T in patients with relapsed or refractory multiple myeloma
Year: 2025
Type: article
Study design: Clinical Trial
Abstract: Multiple myeloma (MM), one of the most common hematological neoplasms worldwide, originates from malignant plasma cells in the bone marrow. MM remains an incurable disease, although continued treatment advancements have markedly increased overall survival. Many patients with MM eventually experience
Source: Cancer Biology and Medicine
Authors: Gaofeng Zheng, Ruyi Xu, Heng Mei, Xiaoyan Han, Donghua He, Yanling Weng, Cheng Wen, Zhuoxiao Cao, Zhen Cai
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,500
Award: G8313397666
OpenAlex ID: W4415384199
FWCI:
Cites:
Cited by:
Related to: